Jumbo Interactive Limited Soars Up – Outstanding Half Year Results And Outlook For FY19


On 7 December 2018, Jumbo Interactive Limited (ASX: JIN) highlighted updates with regards to the trading during half year period ending December 2018, FY2019 outlook, the appointment of the director and exercise of option/share sale program.

For the half-year period ending 31 December 2018, there was an overall increase in the continuing operations as compared to HY Dec 2018 guidance report with the HY December 2017 actual data. The total transaction value of the company has been forecast to witness growth of 64%. The revenue of the company is expected to have 55% growth. There is an indicative increase in NPBT, Income tax expense, NPAT, EBIT, EBITDA – to be above 100%. NPBT will be up about 126%, income tax expense by 133%, NPAT rise by 123%, EBIT also up by 129% and EBITDA to be up 103%. There will also be an increase in the number of large jackpots this year by 17%. 

Based on the FY2019 June guidance report, when compared with the FY June 2018, the company expects that there will be growth in the total transaction value by 44%. The revenue margin is expected to be around 20.8% and EBIT margin is expected to be around 53%. There will also be an increase in the net profit after tax by 77%. The NPAT attributable to the members of the company will be up by 69%. There will also be an increase in the large jackpots by 16%. Income tax expense is also expected to go up by 80%.

Another important update shared to the investors was the appointment of Mr. Giovanni Rizzo to the board from 1 January 2019. He will join the board as the director. He has 14 years of experience with the Tatts Group in Australia and 5 years experience as a head of the investor relation in South Africa. He worked for 2 years with Century Casinos Africa which is the subsidiary unit of NASDAQ listed Century Casinos, Inc. He worked as an Audit manager in gaming for a period of 5 years with PWC in South Africa.

The company further shares an update with regards to the exercise of option and its share sale program. In this, the company wishes that its Key Management Personnel like Mr. Mike Veverka who is the CEO and Executive Director to exercise its option which should not exceed 2 million options. It’s his choice to sell few or all the shares allotted shares by 30 June 2019. However, he wishes to sell a few shares and he wants to continue as a significant shareholder of the company.

At present, the company has 3 set of options. 2 out these 3 have been vested and the remaining one is not yet vested.

There are 250,000 options which have an exercise price of $1.75 with the expiry date 18 November 2020. There are another 50,000 options which have an exercise price of $2.25 with the expiry date of 2 February 2022 and another 3,10,000 options with an exercise price of $3.50 with the expiry date of 15 November 2022.

By the end of the trading on 7 December 2018, the market price of the share increased by 3.651% with the stock holding a market capitalization of A$458.66 million.

  • Disclaimer

    This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report